TP53 and hepatocellular carcinoma: For instance, wild-type transgenic zebrafish expressing the HBV X (HBx) antigen under the control of the liver-specific promoter fabp10a do not develop hepatocellular carcinoma (HCC) whereas tp53−/− transgenics do develop HCC [142,154].